T Takeuchi, E Higashihara, K Nomura, N Moriyama, Y Aso, H Demura
{"title":"羊黄体生成素对肾大部切除大鼠的促肾作用。","authors":"T Takeuchi, E Higashihara, K Nomura, N Moriyama, Y Aso, H Demura","doi":"10.1507/endocrj1954.39.109","DOIUrl":null,"url":null,"abstract":"<p><p>Some of luteinizing hormone (LH) isoforms can stimulate renal growth. The objective of this study is to determine whether the administration of LH modifies subtotal nephrectomy-induced chronic renal failure. Castrated 3/4-nephrectomized male rats were divided into four groups of seven each and fed a low-protein (6%) diet. Ovine LH with renotropic activity (40 micrograms/day) or vehicle only (control) was given for three weeks or six weeks. Compared with controls, remnant kidney weights (% body weight) in LH-treated rats had increased significantly at three weeks (0.385 +/- 0.019 vs 0.443 +/- 0.052, P less than 0.02), but not at six weeks (0.281 +/- 0.004 vs 0.272 +/- 0.013). 24 h creatinine clearance (ml/day/100 g body weight) increased significantly both by three weeks (242 +/- 58 vs 301 +/- 36, P less than 0.05), and six weeks (323 +/- 55 vs 395 +/- 10, P less than 0.01). Urinary thromboxane B2 excretion increased in LH-treated rats, suggesting that hemodynamic changes may play a role in increasing creatinine clearance. Our results suggest that renotropically active oLH stimulated the glomerular function in castrated rats with reduced renal mass. Further study may clarify its clinical usefulness.</p>","PeriodicalId":11534,"journal":{"name":"Endocrinologia japonica","volume":"39 1","pages":"109-14"},"PeriodicalIF":0.0000,"publicationDate":"1992-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1507/endocrj1954.39.109","citationCount":"3","resultStr":"{\"title\":\"The renotropic effect of ovine luteinizing hormone on subtotally nephrectomized rats.\",\"authors\":\"T Takeuchi, E Higashihara, K Nomura, N Moriyama, Y Aso, H Demura\",\"doi\":\"10.1507/endocrj1954.39.109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Some of luteinizing hormone (LH) isoforms can stimulate renal growth. The objective of this study is to determine whether the administration of LH modifies subtotal nephrectomy-induced chronic renal failure. Castrated 3/4-nephrectomized male rats were divided into four groups of seven each and fed a low-protein (6%) diet. Ovine LH with renotropic activity (40 micrograms/day) or vehicle only (control) was given for three weeks or six weeks. Compared with controls, remnant kidney weights (% body weight) in LH-treated rats had increased significantly at three weeks (0.385 +/- 0.019 vs 0.443 +/- 0.052, P less than 0.02), but not at six weeks (0.281 +/- 0.004 vs 0.272 +/- 0.013). 24 h creatinine clearance (ml/day/100 g body weight) increased significantly both by three weeks (242 +/- 58 vs 301 +/- 36, P less than 0.05), and six weeks (323 +/- 55 vs 395 +/- 10, P less than 0.01). Urinary thromboxane B2 excretion increased in LH-treated rats, suggesting that hemodynamic changes may play a role in increasing creatinine clearance. Our results suggest that renotropically active oLH stimulated the glomerular function in castrated rats with reduced renal mass. Further study may clarify its clinical usefulness.</p>\",\"PeriodicalId\":11534,\"journal\":{\"name\":\"Endocrinologia japonica\",\"volume\":\"39 1\",\"pages\":\"109-14\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1507/endocrj1954.39.109\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrinologia japonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1507/endocrj1954.39.109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinologia japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1507/endocrj1954.39.109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
一些黄体生成素(LH)异构体可以刺激肾脏生长。本研究的目的是确定给药黄体生成素是否能改变肾大部切除术引起的慢性肾功能衰竭。将切除3/4肾的雄性大鼠分为4组,每组7只,喂食低蛋白(6%)饮食。具有促肾活性(40微克/天)的羊LH或只给药(对照)三周或六周。与对照组相比,lh处理大鼠的残余肾重(%体重)在第3周显著增加(0.385 +/- 0.019 vs 0.443 +/- 0.052, P < 0.02),但在第6周无显著增加(0.281 +/- 0.004 vs 0.272 +/- 0.013)。24 h肌酐清除率(ml/d /100 g体重)在第3周(242 +/- 58 vs 301 +/- 36, P < 0.05)和第6周(323 +/- 55 vs 395 +/- 10, P < 0.01)均显著增加。lh治疗大鼠尿血栓素B2排泄增加,提示血流动力学改变可能在肌酐清除率增加中起作用。我们的研究结果表明,嗜电性活性oLH刺激了去势大鼠肾肿块减少的肾小球功能。进一步的研究可能阐明其临床应用价值。
The renotropic effect of ovine luteinizing hormone on subtotally nephrectomized rats.
Some of luteinizing hormone (LH) isoforms can stimulate renal growth. The objective of this study is to determine whether the administration of LH modifies subtotal nephrectomy-induced chronic renal failure. Castrated 3/4-nephrectomized male rats were divided into four groups of seven each and fed a low-protein (6%) diet. Ovine LH with renotropic activity (40 micrograms/day) or vehicle only (control) was given for three weeks or six weeks. Compared with controls, remnant kidney weights (% body weight) in LH-treated rats had increased significantly at three weeks (0.385 +/- 0.019 vs 0.443 +/- 0.052, P less than 0.02), but not at six weeks (0.281 +/- 0.004 vs 0.272 +/- 0.013). 24 h creatinine clearance (ml/day/100 g body weight) increased significantly both by three weeks (242 +/- 58 vs 301 +/- 36, P less than 0.05), and six weeks (323 +/- 55 vs 395 +/- 10, P less than 0.01). Urinary thromboxane B2 excretion increased in LH-treated rats, suggesting that hemodynamic changes may play a role in increasing creatinine clearance. Our results suggest that renotropically active oLH stimulated the glomerular function in castrated rats with reduced renal mass. Further study may clarify its clinical usefulness.